GlassScriptPhysician profile
Isabel Leal
NPI 1235580010
$912.36
in general payments reported to CMS, 2019-2025
23 companies · $606 in 2025
The $606 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.46 · 2024: $239 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.04 | 2024-2025 | |
| Ucb, INC. | $110.61 | 2024-2025 | Rystiggo, Zilbrysq, Fintepla |
| Axsome Therapeutics, INC. | $106.63 | 2025 | Symbravo |
| Biogen, INC. | $93.67 | 2023-2024 | Vumerity, Tysabri |
| Averitas Pharma INC. | $56.09 | 2024-2025 | Qutenza |
| Alexion Pharmaceuticals, INC. | $51.44 | 2023-2024 | Ultomiris |
| Novocure INC. | $45.91 | 2024 | Optune |
| Telix Pharmaceuticals | $41.86 | 2025 | Illuccix |
| Sk Life Science, INC. | $34.39 | 2025 | |
| Springworks Therapeutics, INC. | $34.25 | 2024-2025 | Gomekli |
| Otter Pharmaceuticals, LLC | $33.21 | 2025 | Sympazan |
| Lilly USA, LLC | $21.12 | 2024 | Emgality, Reyvow |
| Neurocrine Biosciences, INC. | $18.15 | 2025 | |
| Lundbeck LLC | $17.77 | 2025 | Rexulti |
| Servier Pharmaceuticals LLC | $16.43 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $16.35 | 2025 | Valtoco |
| Octapharma USA, INC. | $16.18 | 2025 | Panzyga |
| Csl Behring | $15.69 | 2025 | Hizentra |
| Tonix Medicines, INC. | $15.06 | 2025 | Zembrace Symtouch |
| Jazz Pharmaceuticals INC. | $14.03 | 2025 | |
| Aucta Pharmaceuticals, INC. | $14.01 | 2025 | Motpoly Xr |
| Grifols USA, LLC | $13.95 | 2025 | Gamunex-C |
| Hologic Sales and Service, LLC | $13.52 | 2025 | Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Leal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.